| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 54 |
| 1 | CYCLOPHOSPHAMIDE | 44 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 44 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 44 |
| 4 | METHOTREXATE SODIUM | 43 |
| 5 | METHOTREXATE | 38 |
| 6 | MONTELUKAST SODIUM | 36 |
| 7 | INFLIXIMAB | 34 |
| 8 | PREDNISOLONE | 34 |
| 9 | PREDNISOLONE ORAL | 34 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | 1 | 0.0081 |
| 1 | FOSAMPRENAVIR CALCIUM | 1 | 0.0076 |
| 2 | MEFENAMIC ACID | 10 | 0.0045 |
| 3 | MINOCYCLINE | 24 | 0.0020 |
| 4 | DEXCHLORPHENIRAMINE MALEATE | 2 | 0.0020 |
| 5 | MOMETASONE FUROATE MONOHYDRATE | 1 | 0.0020 |
| 6 | MINOCYCLINE HYDROCHLORIDE | 8 | 0.0013 |
| 7 | AVACOPAN | 6 | 0.0009 |
| 8 | ESOMEPRAZOLE SODIUM | 2 | 0.0008 |
| 9 | ERGOCALCIFEROL | 23 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 116 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 54 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 54 |
| 3 | Alkylating Drug [EPC] | 44 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 39 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 36 |
| 6 | Purine Antimetabolite [EPC] | 25 |
| 7 | Interleukin-5 Antagonist [EPC] | 24 |
| 8 | Provitamin D2 Compound [EPC] | 23 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 24 | 0.0349 |
| 1 | Complement 5a Receptor Antagonist [EPC] | 6 | 0.0009 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 3 | Provitamin D2 Compound [EPC] | 23 | 0.0008 |
| 4 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 5 | Leukotriene Receptor Antagonist [EPC] | 11 | 0.0004 |
| 6 | Calcitonin [EPC] | 1 | 0.0003 |
| 7 | Protease Inhibitor [EPC] | 12 | 0.0003 |
| 8 | Purine Antimetabolite [EPC] | 25 | 0.0003 |
| 9 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |